866-997-4948 (US-Canada Toll Free)

China Research and Intelligence Co., Ltd. (CRI) is engaged in market research in many industrial fields such as pharmaceuticals, automobiles, manufacture and consumer goods. CRI also provide feasibiltiy study, survey, interviews, etc. in China. CRI is always aiming to deliver success to clients.

  • Investigation Report on China Doxofylline Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Pharmaceutical

    30 Pages

    With the climatic and environmental changes, seasonal asthma has become the main reason for respiratory ailments. According to an epidemiological survey, the incidence of respiratory ailments is 16% of the incidence of all diseases. About 280 million people in the world suffer from different degrees of seasonal asthma. The situation is more serious in industrialized countries and regions where...

    USD 2000View Report
  • Investigation Report on China Octreotide Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Pharmaceutical

    30 Pages

    Octreotide, an octapeptide that mimics natural somatostatin, has been widely used in clinic for the treatment of upper gastrointestinal variceal hemorrhage and stomach ulcer bleeding, acute pancreatitis, endocrine tumors. First approved to be sold in 1996, octreotide was developed by Novartis AG under the trade name of Sandostatin. The approved indications at that time were acromegaly,...

    USD 2000View Report
  • Investigation Report on China Edaravone Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Pharmaceutical

    30 Pages

    Cerebrovascular disease is one of the three principal diseases that can cause people to death. Acute cerebral infarction which occupies 70% of cerebrovascular disease has a disability rate of 50%-70% and a recurrence rate of 40%. And one thing to be noted is that the more relapses people have, the higher the mortality and disability. Acute cerebral infarction, one of the serious...

    USD 2000View Report
  • Investigation Report on China Atorvastatin Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Pharmaceutical

    30 Pages

    With the change of life styles brought about by the economic development and the rising incomes, the number of hyperlipidemia patients in China keeps growing, being estimated to reach 160-200 million in the near future. Atorvastatin, a common drug that can lower blood cholesterol levels, was developed by Pfizer under the trade name of Lipitor. Boasting of nearly 20 years of use in over...

    USD 2000View Report
  • Investigation Report on China Ezetimibe Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Pharmaceutical

    20 Pages

    With the sustained economic development and the improvements in diet, Chinese people’s blood fat level rises too. Many local epidemiological studies on blood fat have proved that a conservative estimate of the incidence of hyperlipemia is 7%-8% while the actual incidence might be above 10%. Over 100 million people in China have to receive cholesterol-lowering therapy, more so with the...

    USD 2000View Report
  • Investigation Report on China Methylprednisolone Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Pharmaceutical

    30 Pages

    Ever since the 1990s, steroid has entered its golden age with over 120 varieties being made for application and sales value in the global market increasing by 10%-15% each year. During the process of product restructuring and industrial development, steroid’s Active Pharmaceutical Ingredients (APIs) made in China take an important position in the global market. Out of all the varieties...

    USD 2000View Report
  • Investigation Report on China Desloratadine Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Pharmaceutical

    30 Pages

    Histamine, a substance which can lead to inflammation and anaphylaxis, is one of the important chemical mediators of immediate anaphylaxis (the most common type I allergy in clinic). The incidence of allergy has always been high and shows an increasing trend. According to the American Acadymy of Allergy, Asthma and Immunology, allergy has become the sixth chronic disease in the US with 20%-40%...

    USD 2000View Report
  • Investigation Report on China Budesonide Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Therapeutic Area

    30 Pages

    With the climatic and environmental changes, seasonal asthma has become the main reason for respiratory ailments. According to an epidemiological survey, the incidence of respiratory ailments is 16% of the incidence of all diseases. About 280 million people in the world suffer from different degrees of seasonal asthma, more so in industrialized countries and regions where tobacco consumption...

    USD 2000View Report
  • Investigation Report on China Celecoxib Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Pharmaceutical

    20 Pages

    Currently, there are over 30 million people around the world using non-steroidal anti-inflammatory drugs (NSAIDs) as anti-inflammatory pain-relief drugs. However, many drugs under the category of NSAIDs cause gastrointestinal adverse reactions such as ulcer, perforation and bleeding. The latest research has shown that among all the NSAIDs, celecoxib reports the lowest number of cases of...

    USD 2000View Report
  • Investigation Report on China Insulin Lispro Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Pharmaceutical

    20 Pages

    According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients has reached 382 million in the world, 80% of which come from middle income and low income countries and the figure demonstrates a fast rising trend. It is estimated that by 2035, there will be nearly 592 million...

    USD 2000View Report
  • Investigation Report on China Recombinant Factor Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Pharmaceutical

    30 Pages

    Hemophilia is a hereditary bleeding disorder caused by a lack of clotting factor or Ⅸ, though not rare, which affects mostly males. Hemophilia A (clotting factor deficiency) is the most common form of the disorder. The number of the cases of hemophilia is about over 0.4 million around the world while that in China is about 0.06-0.1 million, among which 80% lack clotting factor while over...

    USD 2000View Report
  • Investigation Report on China Tacrolimus Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Pharmaceutical

    30 Pages

    Tacrolimus (also FK506) is a macrolide lactone immunosuppressive drug discovered from a soil sample that contained the bacterium Streptomyces tsukubaensis in 1984 by Fujisawa Pharmaceutical Co., Ltd. Tacrolimus acts like cyclosporine and its systemic use is mainly for the prevention of allograft rejection and the treatment of immune disease. Different from cyclosporine, it can penetrate...

    USD 2000View Report
  • Investigation Report on China Capecitabine Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Pharmaceutical

    30 Pages

    Capecitabine, developed by F. Hoffmann-La Roche Ltd, entered the markets in the US, Canada and Sweden in 1998 under the trade name of Xeloda and then spread through over 80 countries and regions in 2 years. In Mar. 2001, capecitabine entered China to be clinically used for the treatment of advanced breast cancer, colorectal cancer and other solid tumors. The chemotherapy for colorectal cancer...

    USD 2000View Report
  • Investigation Report on China Liraglutide Market, 2011-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Pharmaceutical

    25 Pages

    As economy develops and living standards improve, Chinese people’s dietary pattern changes, resulting in excess heat. Meanwhile, the drop in physical activities leads to the increased obesity rate. Other factors like the ageing population also play a role in the rapid increase of diabetes incidence in China. Liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, was developed...

    USD 2000View Report
  • Investigation Report on China Insulin Detemir Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Chemicals

    20 Pages

    As economy develops and living standards improve, Chinese people’s dietary pattern changes with heat, protein and fat coming from animals instead of vegetables, resulting in excess heat. Besides, people’s ignorance of diabetes and the drop in physical activities lead to obesity. Other factors like the ageing population also play a role in the rapid increase of diabetes incidence in...

    USD 2000View Report
  • Investigation Report on China Oxiracetam Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Chemicals

    30 Pages

    According to the National bureau of statistics of China, by the end of 2014, the number of Chinese aged above 60 years old is 212.42 million, occupying 15.5% of the total population; the number of Chinese aged above 65 is 137.55 million, occupying 10.1% of the total population. Senile dementia poses a serious threat to old people. According to statistics, about 10% of people aged above 60...

    USD 2000View Report
  • Investigation Report on China Linezolid Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Chemicals

    20 Pages

    Infection caused by bacteria that are resistant to antibiotics is spreading over the world with increasing infection rate and mortality rate, which has posed a serious threat to human health. In 2004, National Nosocomial Infection Surveillance reported that people infected by Methicillin Resistant Staphylococcus Aureus (MRSA) take up 63.3% of all patients with nosocomial infection of...

    USD 2000View Report
  • Investigation Report on China Imatinib Mesylate Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Chemicals

    20 Pages

    The mortality of leukemia ranks sixth among tumors while its incidence and mortality ranks first among malignant tumors for teenagers. The incidence of leukemia reaches two age peaks: 0-9 years old and above 60 years old. Imatinib Mesylate was a tyrosine kinase inhibitor developed by Novartis. On May. 10, 2001, Imatinib Mesylate got FDA’s express approval with the trade name of...

    USD 2000View Report
  • Investigation Report on China Meropenam Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Chemicals

    30 Pages

    Meropenam, developed together by Sumitomo Pharmaceuticals Co., Ltd and Imperial Chemical Industries Ltd, belongs to the second generation of broad-spectrum carbapenem and the first carbapenem which can be used alone. In 2014, the sales value of meropenam in the global market reached top to USD 1413 million with year-on-year growth of 2.91%. Meropenam is the carbapenem with the largest...

    USD 2000View Report
  • Investigation Report on China Olmesartan Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Pharmaceutical

    20 Pages

    Hypertension is the most dangerous factor that leads to the occurrence and resulting death of heart disease, cerebrovascular disease and kidney disease. According to the statistics of WHO, by 2030, nearly 23.6 million around the world will die of cardiovascular disease especially heart disease and apoplexy each year. With the change of life styles brought about by economic development,...

    USD 2000View Report
  • Investigation Report on China Nifuratel Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Chemicals

    30 Pages

    Gynecological inflammation is a disease that troubles contemporary women. According to WHO’s survery on the health conditions of women all over the world, the incidence of gynecological disease has reached over 65% and over 70% among women of childbearing age. The number of cases of urinary system infections has hit over 300 million around the world, which leads to the rapid expansion of...

    USD 2000View Report
  • Investigation Report on China Tamsulosin Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Chemicals

    30 Pages

    Benign Prostate Hyperplasis (BPH) is prevalent among elderly men, influencing one third of those aged above 50. BPH is a benign histopathological disease characterized by hyperplasia of stromal and epithelial cells which results in enlarged prostate and then compressed urethra that makes urination difficult. BPH is treatable with medication and operation. Two main categories of drugs are...

    USD 2000View Report
  • Investigation Report on China Voriconazole Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Pharmaceutical

    30 Pages

    In recent years, the abuse of antibiotics has resulted in the mass generation of drug-resistant strains and the increased incidence of fungal infection deep seated in tissues. On the other hand, as the number of patients with immune deficiency increases and people take human organ transplant, interventional treatment and chemotherapeutic agents for tumor, the incidence of fungal infection has...

    USD 2000View Report
  • Investigation Report on China Tegafur, Gimeracil and Oteracil (Tegafur/gimeracil/oteracil) Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Chemicals

    30 Pages

    Tegafur, gimeracil and oteracil (Tegafur/gimeracil/oteracil), a fluorouracil derivative, is an oral biological anti-cancer agent made up of tegafur (FT), gimeracil (CDHP) and oteracil (Oxo). In 1999, it was approved to treat advanced gastric cancer and then such indications as head and neck neoplasm, inoperable or unresectable breast cancer, non-small cell carcinoma, colon cancer, pancreatic...

    USD 2000View Report
  • Investigation Report on China Tropisetron Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Chemicals

    30 Pages

    Cancer patients are afraid of such adverse reactions as nausea and emesis caused by chemotherapy. Severe nausea and vomiting will make future chemotherapy a daunting experience for patients. They may even feel unwilling or give up further chemotherapy, which will make chemotherapy difficult to continue. 5-HT3 receptor antagonist, an antiemetic, acts by competitively preventing 5-HT from...

    USD 2000View Report
  • Investigation Report on China Phosphocreatine Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Chemicals

    30 Pages

    The global epidemic trend shows that cardiovascular disease has become one of the serious threats to human health whose incidence and death rate has exceeded that of malignant tumor and leapt to the first. According to the World Health Organization (WHO), about 17 million people die of cardia-cerebrovascular disease, among which 50% die of acute myocardial infarction and cerebral infarction...

    USD 2000View Report
  • Investigation Report on China Rivaroxaban Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Chemicals

    20 Pages

    Venous Thrombus Embolism (VTE), the general term for deep vein thrombosis (DVT) and pulmonary embolism (PE), poses a grave threat to those patients who have accepted Total Hip Replacement (THR) or Total Knee Replacement (TKR). It is estimated that blood clots form in 50% of THR patients and 60% of TKR patients.  According to some experts, rivaroxaban and dabigatran are the most...

    USD 2000View Report
  • Investigation Report on China Tiotropium Bromide Market, 2010-2019

    Jun 2015

    By China Research and Intelligence Co., Ltd. (CRI)

    Pharmaceutical

    20 Pages

    In recent years, various allergic diseases demonstrate an increasing trend under the influence of global environmental changes, leading to the occurrence of seasonal cough and asthma in winter and spring. Affected by tobacco, dust and pollutants, the incidence of chronic obstructive pulmonary disease (COPD) is still on the rise. COPD is a chronic pulmonary disease characterized by incompletely...

    USD 2000View Report
  • Research Report on Hemodialysis Industry in China : 2014-2018

    Sep 2014

    By China Research and Intelligence Co., Ltd. (CRI)

    Medical Equipments

    50 Pages

    Hemodialysis (also HD) is one of the replace therapy for patients with acute and chronic renal failure. There are globally 2.2 million uremia patients (end stage renal disease, ESRD) receiving dialysis treatment, including over 89% of them receiving hemodialysis. As the cost of hemodialysis is high, most dialysis patients are concentrated in developed regions like Europe and the U.S. The...

    USD 1800View Report
  • Research Report on China Avian Influenza Vaccine Industry : 2014-2018

    Sep 2014

    By China Research and Intelligence Co., Ltd. (CRI)

    Pharmaceutical

    50 Pages

    Many countries choose to kill all infected poultry to control avian influenza, instead of immunizations. The total number of poultry exceeds 10 billion in China. Epidemic diseases, which are difficult to control, will result in huge losses. Therefore, it is quite necessary to immunize the poultry with avian influenza vaccines.  Avian influenza vaccines have been used for more than...

    USD 1800View Report